Literature DB >> 1260539

Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis.

K G Johnson, I J McDonald, M B Perry.   

Abstract

Cellular and free lipopolysaccharides obtained from Neisseria catarrhalis and Branhamella catarrhalis were found to be essentially identical. Both cellular and free lipopolysaccharides contained core-oligosaccharides of the following composition: D-glucose (4 mol), D-galactose (1 mol), 2-amino-2-deoxy-D-glucose (1 mol), and 3-deoxy-D-manno-octulosonic acid. Aldoheptose and phosphate components were below levels of detection. Several physical methods indicated that all core-oligosaccharide preparations were identical. Lipid A preparations from cellular and free lipopolysaccharides of both organisms were qualitatively and quantitatively similar; they were composed of decanoic acid, dodecanoic acid, 3-hydroxy dodecanoic acid, 2-amino-2-deoxy-D-glucose, phosphate, and ethanolamine. The results tend to justify the transfer of Neisseria catarrhalis to the genus Branhamella.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260539     DOI: 10.1139/m76-072

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  7 in total

1.  Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M Van Den Abeele
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 2.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 3.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

4.  A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.

Authors:  K Oishi; H Tanaka; F Sonoda; S Borann; K Ahmed; Y Utsunomiya; K Watanabe; T Nagatake; M Vaneechoutte; G Verschraegen; K Matsumoto
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Serological identification of Branhamella catarrhalis. Serological evidence for infection.

Authors:  I Eliasson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.

Authors:  J S Fomsgaard; A Fomsgaard; N Høiby; B Bruun; C Galanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.